Good job. Seems a little conservative, but that is ok. I'm wondering if at or around the 10K Rx number you may want to consider an acceleration rate in Rx occurring though.
I think he feels reporting on ARNA will be how he makes his bones in the analysis/financial reporting world. If ARNA does well he claim he's been covering it 'cause he knew it was going to do well. If it were to fail he could claim he's been covering it cause he had concerns. Either way as many have mentioned his articles are just redundant and boring with no real information value at all.
Why does anyone even read what he writes weekly? Every article he writes is simply wordsmithing. No useful information is ever conveyed, although his writing style and use of charts suggests he has special insight that no one else has. Just ignore it.
Requires a subscription to those services to get that data. Adam F used to tweet it early in the day when the slow launch confirmed his negative views on ARNA. He hasn't been doing that now.
Has a group of investors ever considered pooling resources and getting a subscription to the IMS or Symphony data reporting? I'm sure it is several thousand dollars per year.
Green is good, but I won't be celebrating until I see it go back above $6 and beyond. 2014 will be the year though!!
The volume is pretty low. Not sure why you are excited. If I saw 10,000 or so Jan, Feb , or Mar 2014 $10+ call option volume, that would be exciting.
Don't know. Whoever bought the puts must feel they know something. But as I said above, the options trade world has some crazy gamblers. In this case I think the put seller will get the best side of that options trade.
yes indeed. And if the buyer paid $1.5x for the put option as shown in the options trading summary for the $5 Jan 2015 puts, they have to hope for a $3.4x price before they make any money.
Lots of gamblers in the options trading world. The person writing the $5 put options and collecting the $1.5x premium will get the best of this option trade IMO. Whoever bought them has to hope the share price is below $3.47 sometime by Jan, 2015. I took the opposite action a few weeks ago and bought Jan 2015 $3 call options @ $1.86
Looking at option acitivity it looks like there might be an effort to keep it under $550 on Friday close.
It is funny to see the fact of new global markets coming in the next 6 months to 1 year being ignored. Meanwhile weekly Rx numbers are growing, albeit slowly, but that is ok. Higher Rx numbers in 2014 are a given and share price will rise.
People starting weight loss efforts for a new year
400 sales reps calling on physicians
DTC campaign well under way and possible television & expanded internet ads
Weekly growth in Rx numbers
News on upcoming approvals in Canada & Mexico
Resubmission for approval in the EU
All positive catalysts!!
It sounds more like what you are saying is that classification will be very short since both compounds are scheduled already.